Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. (Q50096775)

24 February 2018

title

Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. (English)

1 reference

24 February 2018

main subject

type-1 diabetes

0 references

Salmonella Typhimurium

object named as

Salmonella typhimurium

1 reference

4

Mitchell Kronenberg

1 reference

24 February 2018

Paola Zaccone

1

1 reference

24 February 2018

Tim Raine

2

1 reference

24 February 2018

Stéphane Sidobre

3

1 reference

24 February 2018

Pietro Mastroeni

5

1 reference

24 February 2018

Anne Cooke

6

1 reference

24 February 2018

language of work or name

English

0 references

publication date

1 November 2004

1 reference

24 February 2018

European Journal of Immunology

published in

1 reference

24 February 2018

volume

34

1 reference

24 February 2018

issue

11

1 reference

24 February 2018

page(s)

3246-3256

1 reference

24 February 2018

A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Immunity to systemic Salmonella infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Genetic Control of NKT Cell Numbers Maps to Major Diabetes and Lupus Loci

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

NKT cell defects in NOD mice suggest therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Characterization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Rapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

CD8alpha + dendritic cells originate from the CD8alpha - dendritic cell subset by a maturation process involving CD8alpha , DEC-205, and CD24 up-regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425285

7 January 2021

Identifiers

DOI

10.1002/EJI.200425285

1 reference

24 February 2018

PubMed ID

15376194

1 reference

24 February 2018